Ticker Details
Travere Therapeutics, Inc.
IPO Date:	August 15, 2003
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$5.44B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.59 | 2.93%
Avg Daily Range (30 D):	$1.27 | 2.52%
Avg Daily Range (90 D):	$1.01 | 2.55%

Institutional Daily Volume
Avg Daily Volume:	.26M
Avg Daily Volume (30 D):	1.69M
Avg Daily Volume (90 D):	1.75M

Trade Size
Avg Trade Size (Sh.):	80
Avg Trade Size (Sh.) (30 D):	67
Avg Trade Size (Sh.) (90 D):	71

Institutional Trades
Total Institutional Trades:	4,548
Avg Institutional Trade:	$2.4M
Avg Institutional Trade (30 D):	$4.35M
Avg Institutional Trade (90 D):	$3.71M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$3.83M
Avg Closing Trade (30 D):	$21.18M
Avg Closing Trade (90 D):	$12.52M
Avg Closing Volume:	183.2K

News

May 10, 2026 @ 1:16 PM Validating headline phrasing and editorial resonan... Source: Seena Hassouna

Feb 27, 2026 @ 2:52 PM Your Kidneys Count: American Kidney Fund Urges Ame... Source: American Kidney Fund

Jan 31, 2026 @ 1:50 AM TVTX ALERT: Investigation Launched into Travere Th... Source: Robbins Geller Rudman & Dowd Llp

Jan 13, 2026 @ 11:58 PM TVTX ALERT: Investigation Launched into Travere Th... Source: Robbins Geller Rudman & Dowd Llp

Dec 24, 2025 @ 11:31 PM Why Travere Therapeutics Stock Popped by Nearly 14... Source: Eric Volkman

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.22	$-.4	$.03
Diluted EPS	$-.23	$-.4	$.03
Revenue	$536.2M	$127.2M	$129.69M
Gross Profit	$528.59M	$125.25M	$127.14M
Net Income / Loss	$-21.42M	$-37.1M	$2.73M
Operating Income / Loss	$-57.06M	$-36.92M	$-32.43M
Cost of Revenue	$7.61M	$1.95M	$2.55M
Net Cash Flow	$16.47M	$-14.67M	$-17.9M
PE Ratio

Splits
Nov 08, 2011	1:9